O-GlcNAcylation-inducing treatments inhibit estrogen receptor α expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells.
O-GlcNAcylation (addition of N-acetyl-glucosamine on serine or threonine residues) is a post-translational modification that regulates stability, activity or localization of cytosolic and nuclear proteins. O-linked N-acetylgluocosmaine transferase (OGT) uses UDP-GlcNAc, produced in the hexosamine bi...
Guardado en:
Autores principales: | Shahzina Kanwal, Yann Fardini, Patrick Pagesy, Thierry N'tumba-Byn, Cécile Pierre-Eugène, Elodie Masson, Cornelia Hampe, Tarik Issad |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a4529715b4b24986966e08c9b46a6c7a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role and Function of O-GlcNAcylation in Cancer
por: Jii Bum Lee, et al.
Publicado: (2021) -
O-GlcNAcylation links oncogenic signals and cancer epigenetics
por: Lidong Sun, et al.
Publicado: (2021) -
O-GlcNAcylation is required for B cell homeostasis and antibody responses
por: Jung-Lin Wu, et al.
Publicado: (2017) -
AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation
por: Roselle Gélinas, et al.
Publicado: (2018) -
O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers
por: David E. Spaner, et al.
Publicado: (2021)